In focus · trending topic

Allergy immunotherapy

2 stories · following the connections

Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform

By Nasdaq OMXMar 21, 2018, 12:37 PM UTC

Allovate Therapeutics Announces Issuance of U.S. Patent Covering Novel Oral Mucosal Immunotherapy Platform

By Nasdaq OMXFeb 29, 2016, 12:15 PM UTC